Literature DB >> 28604435

Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.

Lina M Nerlander1, Kristen L Hess, Charles E Rose, Catlainn Sionean, Anna Thorson, Dita Broz, Gabriela Paz-Bailey.   

Abstract

BACKGROUND: Women who inject drugs and who also exchange sex are at increased risk for HIV infection, but data on this population in the United States remain sparse.
METHODS: This study assessed the prevalence of exchanging sex for money or drugs among women who inject drugs using data from the 2009 US National HIV Behavioral Surveillance (NHBS) system. Prevalence of being HIV-positive (testing positive in NHBS), HIV-positive-unaware (reporting being HIV-negative or unknown status but testing positive in NHBS), and risk behaviors and use of services were compared between women who did and did not exchange sex. The association between exchange sex and being HIV-positive-unaware of the infection was examined using multivariate Poisson models with robust standard errors.
RESULTS: Among 2305 women who inject drugs, 39% reported receiving things like money or drugs from ≥1 male partners in exchange for oral, vaginal, or anal sex in the previous 12 months. Women who exchanged sex were more likely to be unemployed, homeless, lack health insurance, have multiple condomless vaginal or anal sex partners, and receptively share syringes. In multivariate analysis, exchange sex was associated with being HIV-positive-unaware (adjusted prevalence ratio 1.97, 95% confidence intervals: 1.31 to 2.97).
CONCLUSIONS: Prevalence of exchange sex was high in this population. Women who exchange sex were more likely to be socially disadvantaged, report sexual and injection risk, and be HIV-positive-unaware. They represent an important group to reach with HIV prevention, testing, and care services.

Entities:  

Mesh:

Year:  2017        PMID: 28604435      PMCID: PMC5681711          DOI: 10.1097/QAI.0000000000001408

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  41 in total

1.  HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-03-02       Impact factor: 17.586

2.  HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz
Journal:  AIDS Behav       Date:  2006-03

3.  Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities.

Authors:  Steffanie A Strathdee; Morgan M Philbin; Shirley J Semple; Minya Pu; Prisci Orozovich; Gustavo Martinez; Remedios Lozada; Miguel Fraga; Adela de la Torre; Hugo Staines; Carlos Magis-Rodríguez; Thomas L Patterson
Journal:  Drug Alcohol Depend       Date:  2007-08-21       Impact factor: 4.492

4.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

Review 5.  Global epidemiology of HIV among female sex workers: influence of structural determinants.

Authors:  Kate Shannon; Steffanie A Strathdee; Shira M Goldenberg; Putu Duff; Peninah Mwangi; Maia Rusakova; Sushena Reza-Paul; Joseph Lau; Kathleen Deering; Michael R Pickles; Marie-Claude Boily
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

6.  Sexual risk behavior among heterosexual intravenous drug users: ethnic and gender variations.

Authors:  D K Lewis; J K Watters
Journal:  AIDS       Date:  1991-01       Impact factor: 4.177

7.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

8.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-11-09

9.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

10.  Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States.

Authors:  J Stan Lehman; Meredith H Carr; Allison J Nichol; Alberto Ruisanchez; David W Knight; Anne E Langford; Simone C Gray; Jonathan H Mermin
Journal:  AIDS Behav       Date:  2014-06
View more
  10 in total

1.  Implementing Respondent-Driven Sampling to Recruit Women Who Exchange Sex in New York City: Factors Associated with Recruitment and Lessons Learned.

Authors:  Sidney A Carrillo; Alexis V Rivera; Sarah L Braunstein
Journal:  AIDS Behav       Date:  2020-02

2.  Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis.

Authors:  Chen Zhang; James McMahon; Janie Simmons; L Lauren Brown; Robertson Nash; Yu Liu
Journal:  AIDS Behav       Date:  2019-10

3.  Exchange Sex Among High School Students-Washington, DC, 2017.

Authors:  Sara K Head; Danice Eaton; Patricia C Lloyd; Aimee McLaughlin; John Davies-Cole
Journal:  J Adolesc Health       Date:  2020-07-14       Impact factor: 5.012

4.  Interpersonal and structural factors associated with receptive syringe-sharing among a prospective cohort of female sex workers who inject drugs.

Authors:  Ju Nyeong Park; Katherine H A Footer; Michele R Decker; Catherine Tomko; Sean T Allen; Noya Galai; Susan G Sherman
Journal:  Addiction       Date:  2019-03-03       Impact factor: 6.526

5.  Factors Associated with Exchange Sex Among Cisgender Persons Who Inject Drugs: Women and MSM-23 U.S. Cities, 2018.

Authors:  Julie Rushmore; Kate Buchacz; Dita Broz; Christine B Agnew-Brune; Michelle L Johnson Jones; Susan Cha
Journal:  AIDS Behav       Date:  2022-06-25

6.  Participants of a mail delivery syringe services program are underserved by other safe sources for sterile injection supplies.

Authors:  Benjamin T Hayes; Jamie Favaro; Dan Coello; Czarina N Behrends; Andrea Jakubowski; Aaron D Fox
Journal:  Int J Drug Policy       Date:  2021-10-05

7.  Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.

Authors:  Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Behav       Date:  2022-04-01

8.  Characterization of Patients Seeking Care at a Sexual Health Clinic Who Report Engaging in Exchange Sex.

Authors:  Medhavi Bole; Christine M Khosropour; Sara N Glick; Lindley A Barbee; Matthew R Golden; Shireesha Dhanireddy; Julia C Dombrowski
Journal:  Sex Transm Dis       Date:  2022-07-04       Impact factor: 3.868

9.  Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.

Authors:  Young Jo; Tyler S Bartholomew; Susanne Doblecki-Lewis; Allan Rodriguez; David W Forrest; Jasmine Tomita-Barber; Juan Oves; Hansel E Tookes
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

10.  Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia.

Authors:  Rebecca Hamilton White; Allison O'Rourke; Michael E Kilkenny; Kristin E Schneider; Brian W Weir; Suzanne M Grieb; Susan G Sherman; Sean T Allen
Journal:  Addiction       Date:  2020-07-14       Impact factor: 6.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.